Internal Medicine, Endocrinology, Diabetes, & Metabolism · Richmond Hill, NY
NPI
1376647701
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
8639 105th St
Richmond Hill, NY, 11418
Phone (718) 847-0063
Medicare paid, 2024
$106K
1,438 services
Medicare patients, 2024
321
Average age 74
Drug cost, 2024
$5.8M
14,029 prescriptions
Company payments, 2025
$52K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kalpana Reddy was code 99214 (office e&m - established), 452 times for 176 patients. In total Kalpana Reddy billed 1,438 services in 25 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 452 | 176 | $97.03 | $44K |
| 99232 Hospital E&M - Subsequent | Facility | 351 | 100 | $62.80 | $22K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 155 | 54 | $25.70 | $3,984 |
| 95251 Test - Miscellaneous | Office | 109 | 52 | $27.37 | $2,984 |
| 99223 Hospital E&M - Initial | Facility | 87 | 80 | $137.81 | $12K |
| 99204 Office E&M - New | Office | 52 | 52 | $124.44 | $6,471 |
| 99222 Hospital E&M - Initial | Facility | 47 | 44 | $104.80 | $4,926 |
| 99212 Office E&M - Established | Office | 31 | 26 | $47.03 | $1,458 |
| 95250 Test - Miscellaneous | Office | 26 | 25 | $123.62 | $3,214 |
| 36415 Venipuncture Blood Collection | Office | 23 | 14 | $8.65 | $199 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 23 | 20 | $12.34 | $284 |
| 99213 Office E&M - Established | Office | 21 | 18 | $64.97 | $1,364 |
| 76536 Ultrasound - Nonspecific | Office | 13 | 12 | $93.63 | $1,217 |
By year: 2022 $107K for 1,196 services; 2023 $124K for 1,507 services; 2024 $106K for 1,438 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 14 | $8.65 | $199 |
Medicare prescription drug claims, 2024
In 2024, the drug Kalpana Reddy prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,350 prescriptions and refills. In total Kalpana Reddy wrote 14,029 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,350 | 1,638 | 232 | $1.5M |
| Jardiance Empagliflozin | 992 | 1,365 | 242 | $769K |
| Metformin Hcl Generic | 952 | 1,513 | 231 | $13K |
| Farxiga Dapagliflozin Propanediol | 668 | 870 | 139 | $469K |
| Levothyroxine Sodium Generic | 536 | 847 | 137 | $4,882 |
| Pioglitazone Hcl Generic | 478 | 713 | 102 | $3,146 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 420 | 784 | 144 | $29K |
| Novolog Flexpen Insulin Aspart | 419 | 586 | 119 | $59K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 413 | 720 | 112 | $106K |
| Novolog Insulin Aspart | 382 | 520 | 79 | $75K |
| Afrezza Insulin Regular, Human | 352 | 464 | 79 | $737K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 351 | 515 | 92 | $23K |
| Atorvastatin Calcium Generic | 336 | 572 | 98 | $1,849 |
| Cequr Simplicity Bolus Insulin Pump, 200 Unit | 327 | 349 | 88 | $145K |
| Nateglinide Generic | 298 | 412 | 72 | $7,667 |
Brand drugs: 7,423 claims; generic drugs: 4,774 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kalpana Reddy $52K ($52K in general payments such as food, travel and fees) from 21 companies. The largest payer was Novo Nordisk Inc with $35K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 43 | $35K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $6,465 |
| CeQur Corporation | 2 | $5,613 |
| Lilly USA, LLC LLY | 5 | $1,698 |
| Beta Bionics, Inc. BBNX | 18 | $887 |
| Mannkind Corporation MNKD | 14 | $426 |
| Amgen Inc. AMGN | 9 | $299 |
| Amneal Pharmaceuticals LLC AMRX | 13 | $286 |
| Madrigal Pharmaceuticals MDGL | 5 | $281 |
| Ascendis Pharma Endocrinology Inc ASND | 8 | $263 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.